SEROPREVALENCE OF ANTI-SARS-COV-2 ANTIBODIES IN FRONT-LINE MEDICAL AND NON-MEDICAL STAFF AT THE JORDAN MEDICAL SERVICES, CAMEROON: DESCRIPTIVE CROSS-SECTIONAL STUDY

Authors

  • Nadège Lylian Doumou A Mvomo Jordan Medical Services, Cameroon
  • Esther Voundi Voundi Faculty of Medicine and Biomedical Sciences of the University of Yaoundé I, Cameroon
  • Ruth Ngongang Jordan Medical Services, Cameroon
  • Yimga Sam Blessing Jordan Medical Services, Cameroon
  • Herman Tchida Tassonwa Jordan Medical Services, Cameroon Catholic University of Central Africa.
  • Eric Nseme Etouckey Faculty of Medicine and Biomedical Sciences of the University of Yaoundé I, Cameroon
  • Haamit Kabir Abba Faculty of Medicine and Biomedical Sciences of the University of Yaoundé I, Cameroon
  • Eric Tollo Chokote Jordan Medical Services, Cameroon
  • Gilles Tchouassi Simeni Jordan Medical Services, Cameroon
  • Jean Paul Assam Assam Faculty of Sciences of the University of Yaoundé I, Cameroon

DOI:

https://doi.org/10.53555/nnpbs.v8i4.1206

Keywords:

Seroprevalence, Health Care Workers, Non-Healthcare Workers, SARS-CoV 2, Cameroon

Abstract

Introduction: Health care personnel on the front line of the COVID-19 pandemic represent a source of transmission. The aim of our study was to assess the seroprevalence of anti-SRAS-Cov-2 antibodies in nursing and non-healthcare staff at the Jordan Medical Services (JMS).

Materials and method: We conducted a descriptive cross-sectional study of JMS staff during April 2021 recruited consecutively after obtaining their informed consent. Immunoglobulin G and M were detected using the Panbio TM COVID-19 IgG/IgM kit. The data collected were analysed using SPSS version 21 software. The Chi-square test was used with a statistical significance of p<0.05.

Results: Of the 170 participants, the most represented age group was [30-40[ years (86, 50.6%) with a female participation rate of 55.9% (95) and a predominance of paramedical staff (90, 52.9%). The seroprevalence of COVID-19 was 6.5% (11) for IgM and 44.7% (76) for IgG. The proportion of paramedical staff who were IgG positive for COVID-19 was statistically significantly higher than that of medical and administrative staff, at 52.2% (p = 0.037). On the other hand, the proportion of participants with a history of COVID-19 positive for IgG was statistically higher than that of the others, at 61.5% (p = 0.016).

Conclusion: Seroprevalence of COVID-19 is high among health care and non-health care personnel, with paramedical personnel and history of COVID-19 as associated factors.

References

Juma CA, Mushabaa NK, Abdu Salam F, Ahmadi A, Lucero-Prisno DE. COVID-19: The Current Situation in the Democratic Republic of Congo. Am J Trop Med Hyg. déc 2020;103(6):2168 70.

Suivez la propagation de la COVID-19 à travers le monde [Internet]. Le Devoir. [Cité 18 oct 2021]. Disponible sur : https://www.ledevoir.com/documents/special/20-03_covid19-carte-dynamique/index.html

Atténuer l’impact de la COVID-19 sur les services de santé essentiels, OMS, 05 novembre 2020.

To KK-W, Tsang OT-Y, Leung W-S, Tam AR, Wu T-C, Lung DC, et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. The Lancet Infectious Diseases. 1 mai 2020;20(5):565 74.

Elsevier. Les professionnels de santé face à la pandémie de la maladie à coronavirus (COVID-19) [Internet]. Elsevier Connect. [Cité 20 oct 2021]. Disponible sur : https://www.elsevier.com/fr-fr/connect/psy/les-professionnels-de-sante-face-a-la-pandemie-de-la-maladie-a-coronavirus-covid-19

Garcia-Basteiro AL, Moncunill G, Tortajada M, Vidal M, Guinovart C, Jiménez A, et al. Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital. Nature Communications [Internet]. 2020 [Cité 12 oct 2021];11. Disponible sur: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343863/

Venugopal U, Jilani N, Rabah S, Shariff MA, Jawed M, Mendez Batres A, et al. SARS-CoV-2 seroprevalence among health care workers in a New York City hospital: A cross-sectional analysis during the COVID-19 pandemic. Int J Infect Dis. janv 2021; 102:63 9.

Etyang AO, Lucinde R, Karanja H, Kalu C, Mugo D, Nyagwange J, et al. Seroprevalence of Antibodies to SARS-CoV-2 among Health Care Workers in Kenya. Clin Infect Dis. 24 avr 2021 ; ciab346.

Venugopal U, Jilani N, Rabah S, Shariff MA, Jawed M, Mendez Batres A, et al. SARS-CoV-2 seroprevalence among health care workers in a New York City hospital: A cross-sectional analysis during the COVID-19 pandemic. Int J Infect Dis. janv 2021; 102:63 9.

Olatunde Olayanju, Olabisi Bamidele, Fabian Edem, Bola Eseile, Abimbola Amoo, Jude Nwaokenye, Chioma Udeh, Gabriel Oluwole, Gabriel Odok, and Nnaemeka Awah. SARS-CoV-2 Seropositivity in Asymptomatic Frontline Health Workers in Ibadan, Nigeria [Internet]. [Cité 19 juill 2021]. Disponible sur : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7790104/

Haoud K, Mellali S, La phytothérapie et les produits naturels au secours de la médecine conventionnelle dans le traitement et la prévention de la COVID-19, Algerian Journal of Health Sciences.vol. 03 num. 03 (2021) 79-87.

Chen H, Zhang X, Liu W, Xue M, Liao C, Huang Z, et al. The role of serum specific- SARS-CoV-2 antibody in COVID-19 patients. Int Immunopharmacol. févr 2021; 91:107325.

Cherif K, Ernandes H, Hannachi S, Chtourou S, Abid R, Ben Moussa M, Besghaier H, Bellaaj R, Battikh R, COVID-19 chez le personnel de santé travaillant à l’Hôpital Militaire de Tunis, STPI et SPILF, 2021, P140.

Hall VJ, Foulkes S, Saei A, Andrews N, Oguti B, Charlett A, et al. COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study. The Lancet. 2021; 397(10286):1725–35.

OMS, Éléments à prendre en considération lors de la mise en œuvre et de l’ajustement des mesures de santé publique et des mesures sociales dans le cadre de l’épidémie de COVID-19, Orientations provisoires, 14 juin 2021.

Published

2022-04-13

How to Cite

Mvomo , N. L. D. A. ., Voundi , E. V. ., Ngongang, R. ., Blessing , Y. S. ., Tassonwa, H. T. . ., Etouckey , E. N. ., Abba , H. K. ., Chokote , E. T. ., Simeni , G. T. ., & Assam , J. P. A. . (2022). SEROPREVALENCE OF ANTI-SARS-COV-2 ANTIBODIES IN FRONT-LINE MEDICAL AND NON-MEDICAL STAFF AT THE JORDAN MEDICAL SERVICES, CAMEROON: DESCRIPTIVE CROSS-SECTIONAL STUDY. Journal of Advance Research in Pharmacy &Amp; Biological Science, 8(4), 1–8. https://doi.org/10.53555/nnpbs.v8i4.1206